Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 330

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease

Open access
Goessling, Wolfram, Massaro, Joseph M., Vasan, Ramachandran S., D'Agostino, Ralph B., Ellison, R. Curtis, Fox, Caroline S.·2008·Gastroenterology

Abstract

Background & Aims Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome. Alanine aminotransferase (ALT) levels are used to detect NAFLD and have also been associated with increased risk for metabolic syndrome, diabetes mellitus and cardiovascular disease. We studied the relationship between ALT levels and these disorders in a long-term follow-up study. Methods Framingham Offspring Heart Study participants (n=2812, mean age 44 years, 56% women) were followed for the development of metabolic syndrome, diabetes, cardiovascular disease, and all-cause mortality using logistic regression (metabolic syndrome, diabetes) or Cox proportional hazards models (cardiovascular disease, all-cause mortality). Results Among individuals at baseline, per 1 standard deviation increase in log ALT level, there were increased odds of the development of metabolic syndrome (odds ratio 1.21, p<0.001) and diabetes (odds ratio 1.48, p<0.001) over 20 years of follow-up. These findings also applied to participants with ALT levels within the normal range (metabolic syndrome odds ratio 1.17, p=0.006; diabetes odds ratio 1.34, p=0.002). There was an increased risk of cardiovascular disease in age-sex adjusted models (hazard ratio 1.23, p<0.001), but this was attenuated in multivariable-adjusted models (hazard ratio 1.05, p=0.27); no association was observed for all-cause mortality. Aspartate aminotransferase levels were found to be associated with an increased risk of only diabetes. Conclusions Both normal and increased levels of ALT are associated with long-term development of multiple metabolic disorders. These results indicate the potential for ALT values as biomarkers for the risk for metabolic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.09.018

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 330

Metadata

Authors
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2008-12
Volume
135
Issue
6
Pages
1935-1944.e1
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2153413362
Cited by
330
References
5
FWCI
15.33
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease. https://app.cochat.ai/papers/10.1053/j.gastro.2008.09.018
The paper
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S. (2008). Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease. Gastroenterology. https://doi.org/10.1053/j.gastro.2008.09.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.